Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
Sivgin S, Karakus E, Kaynar L, Kurnaz F, Pala C, Keklik M, Zararsiz G, Solmaz M, Eser B, Cetin M, Unal A. Sivgin S, et al. Among authors: zararsiz g. Transfus Apher Sci. 2013 Jun;48(3):315-20. doi: 10.1016/j.transci.2013.04.007. Epub 2013 Apr 20. Transfus Apher Sci. 2013. PMID: 23611684
The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.
Sivgin S, Baldane S, Akyol G, Keklik M, Kaynar L, Kurnaz F, Pala C, Zararsiz G, Cetin M, Eser B, Unal A. Sivgin S, et al. Among authors: zararsiz g. Transfus Apher Sci. 2013 Oct;49(2):295-301. doi: 10.1016/j.transci.2013.07.004. Epub 2013 Aug 2. Transfus Apher Sci. 2013. PMID: 23916904 Clinical Trial.
Evaluation of the efficacy and safety of original filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) in CD34(+) peripheral hematopoietic stem cell mobilization procedures for allogeneic hematopoietic stem cell transplant donors.
Sivgin S, Karakus E, Keklik M, Zararsiz G, Solmaz M, Kaynar L, Eser B, Cetin M, Unal A. Sivgin S, et al. Among authors: zararsiz g. Transfus Apher Sci. 2016 Jun;54(3):410-5. doi: 10.1016/j.transci.2016.03.003. Epub 2016 Mar 24. Transfus Apher Sci. 2016. PMID: 27052362 Clinical Trial.
The Prognostic Significance of Elevated Serum Ferritin Levels Prior to Transplantation in Patients With Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation (autoHSCT): Role of Iron Overload.
Sivgin S, Karamustafaoglu MF, Yildizhan E, Zararsiz G, Kaynar L, Eser B, Cetin M, Unal A. Sivgin S, et al. Among authors: zararsiz g. Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S152-8. doi: 10.1016/j.clml.2016.02.006. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27521313
TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients.
Kaynar L, Demir K, Turak EE, Öztürk ÇP, Zararsız G, Gönen ZB, Gökahmetoğlu S, Şıvgın S, Eser B, Köker Y, Solmaz M, Ünal A, Çetin M. Kaynar L, et al. Among authors: zararsiz g. Hematology. 2017 Apr;22(3):136-144. doi: 10.1080/10245332.2016.1238182. Epub 2016 Oct 10. Hematology. 2017. PMID: 27724812 Free article.
Increased Bone Marrow Iron Scores Are Strongly Correlated With Elevated Serum Ferritin Levels and Poorer Survival in Patients With Iron Overload That Underwent Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience.
Sivgin S, Nazlim S, Zararsiz G, Baspinar O, Kaynar L, Deniz K, Cetin M, Unal A, Eser B. Sivgin S, et al. Among authors: zararsiz g. Clin Lymphoma Myeloma Leuk. 2016 Oct;16(10):582-587. doi: 10.1016/j.clml.2016.08.002. Epub 2016 Aug 24. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27769559
144 results